AltMountain

Cure Ventures Fund I, L.P.

Boston, MA · CIK 1863564
Status: no Form D since Apr 2023. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Cure Ventures Fund I, L.P. is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Apr 4, 2023, it has sold $350,456,853 of interests to 44 investors since its first sale in May 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Richard Lim; Cure Ventures Fund I GP, LLC; Louis Tartaglia.

Total raised
$350,456,853Cumulative sales reported on Form D
Investors
44
First sale
May 25, 2021
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Richard Lim; Cure Ventures Fund I GP, LLC; Louis Tartaglia
Latest Form D
Apr 4, 2023

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Raise history

$350,456,853May 24, 2021: $0 raisedMay 20, 2022: $207,868,020 raisedApr 4, 2023: $350,456,853 raisedMay 2021Apr 2023
FiledFilingTotal raisedInvestorsSource
Apr 4, 2023Form D/A (amendment)$350,456,85344SEC.gov ↗
May 20, 2022Form D/A (amendment)$207,868,02025SEC.gov ↗
May 24, 2021Form D$00SEC.gov ↗

3 Form D filings in the SEC's electronic records (2008 onward), the earliest on May 24, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Cure Ventures Fund I, L.P.

What is the minimum investment for Cure Ventures Fund I, L.P.?

Cure Ventures Fund I, L.P.'s latest Form D, filed Apr 4, 2023, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Cure Ventures Fund I, L.P.?

Cure Ventures Fund I, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Cure Ventures Fund I, L.P. raised?

Cure Ventures Fund I, L.P. reports $350,456,853 sold from 44 investors on its Form D filed Apr 4, 2023. This is cumulative sales since the offering began, not current assets or performance.

Where is Cure Ventures Fund I, L.P. based?

Cure Ventures Fund I, L.P. is based in Boston, Massachusetts.

When did Cure Ventures Fund I, L.P. launch?

Cure Ventures Fund I, L.P. reports its first sale in May 2021.

Size compared with every venture capital fund

Raised more than 98% of the 533 venture capital funds based in Massachusetts, and more than 99% of all 14,876 that report sales.

Other funds with the same team

More venture capital funds in Boston

Similar-size venture capital funds in Massachusetts

All venture capital funds in Massachusetts